title: Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: implications for atherogenic risk.
authors.forename: R P
authors.initials: RP
authors.lastname: Lowry
authors.forename: G
authors.initials: G
authors.lastname: Soltys
authors.forename: L
authors.initials: L
authors.lastname: Peters
authors.forename: R
authors.initials: R
authors.lastname: Mangel
authors.forename: A D
authors.initials: AD
authors.lastname: Sniderman
mesh_terms: D000328:Adult; D001055:Apolipoproteins B / Q000097:blood*; D001161:Arteriosclerosis / Q000209:etiology*; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000209:etiology*; D006951:Hyperlipoproteinemias / Q000209:etiology*; D016030:Kidney Transplantation; D008075:Lipoproteins, HDL / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D012306:Risk
chemical_list: D001055:Apolipoproteins B; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL